The trajectory of the erectile dysfunction drug presents a intricate picture for investors. While the initial launch generated substantial profits, the lapse of its exclusive rights opened the floodgates to cheaper https://dftsocial.com/story22760130/viagra-and-pharma-a-precarious-opportunity